Analytical Validation of an LC-MS/MS Method for Simultaneous Quantification of Multiple Immunosuppressants in Microvolume Whole Blood
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136358 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kenichi Aizawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Research, Clinical Research Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Tochigi, Japan. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Immunosuppressive Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jichi Medical University Hospital.
Abstract (Originalsprache)
Immunosuppressants are essential for preventing allograft rejection; however, they require therapeutic drug monitoring to maintain efficacy and to prevent severe complications such as opportunistic infections. Calcineurin inhibitors (CIs) are primarily distributed in red blood cells, whereas mycophenolic acid (MPA) and its metabolites are found in plasma. These differences necessitate separate analyses for each drug, increasing laboratory workload, analytical complexity, and patient burden. We developed a liquid chromatography–tandem mass spectrometry method for simultaneous quantification of CIs such as tacrolimus (Tac), everolimus (Eve), sirolimus (Sir), cyclosporine A (CycA) and MPA in 2.8-µL whole-blood samples, with a hematocrit-based correction to estimate plasma-equivalent MPA concentrations. Performance of this method was assessed by comparison with conventional immunoassay results using linear regression and Bland–Altman analyses, demonstrating excellent agreement, with strong linearity (R2 > 0.995) at 0.900), indicating high accuracy and reproducibility. This new approach may be particularly beneficial for hospitalized patients with limited venous access, pediatric populations, and in remote care settings where frequent blood sampling is challenging because of simultaneous quantification and fewer sample volume requirements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational Research, Clinical Research Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Tochigi, Japan.
- Clinical Pharmacology Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Tochigi, Japan.
- Solutions COE, Analytical & Measuring Instruments Division, Shimadzu Corporation, Kawasaki 210-0821, Kanagawa, Japan.
- Division of Renal Surgery and Transplantation, Department of Urology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
- Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
- Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
ORCID-Profile: Takahiro Goda, Yasunaru Sakuma, Daiki Iwami
Förderung
- Jichi Medical University Hospital
Zitieren
APA
Aizawa, K., Kimura, N., Goda, T., Nishida, S., Sakuma, Y., Iwami, D., & Nagai, R. (2025). Analytical Validation of an LC-MS/MS Method for Simultaneous Quantification of Multiple Immunosuppressants in Microvolume Whole Blood. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136358
Vancouver
Aizawa K, Kimura N, Goda T, Nishida S, Sakuma Y, Iwami D, et al. Analytical Validation of an LC-MS/MS Method for Simultaneous Quantification of Multiple Immunosuppressants in Microvolume Whole Blood. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136358
BibTeX
@article{Aizawa2025,
author = {Aizawa, Kenichi and Kimura, Natsuka and Goda, Takahiro and Nishida, Sho and Sakuma, Yasunaru and Iwami, Daiki and Nagai, Ryozo},
title = {Analytical Validation of an LC-MS/MS Method for Simultaneous Quantification of Multiple Immunosuppressants in Microvolume Whole Blood},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136358}
}
EUVIMED